the attendant toxicity issues and separation problems,10 is
far from ideal for large scale synthesis. We report herein a
palladium-catalyzed process that provides 11H-indolizino-
[1,2-b]quinolin-9-ones from the same two precursors as the
tandem radical process. The new process already func-
tions well for small-scale preparations, and the results form
the basis for the development of a practical large-scale
method.
Scheme 1
p-Methoxyphenylisonitrile 8a and N-propargylpyridone 9a
were chosen as substrates for an initial survey of reaction
conditions because the target product 10a from this reagent
pair has a substitution pattern similar to that of DB-67 7.
Treatment of 8a and 9a with 10% Pd(OAc)2, 20% Ph3P, and
Et3N in MeCN at 80 °C gave only traces of the product 10a
as assayed by TLC analysis against an authentic sample
(Scheme 2). In follow-up reactions, we varied the Pd
anticancer agents, and one of the most promising new
compounds, DB-67 7, is currently in preclinical develop-
ment.9
Scheme 2
catalysts, ligands, solvents, temperatures, and bases.11 We
learned that a phosphine ligand was not needed for the
reaction. Toluene was found to be a suitable solvent, and
the reaction occurred at room temperature. Addition of a base
proved helpful, and among the bases tried, Ag2CO3 proved
to be the best.
While the generality and simplicity of the cascade radical
addition approach are nearly ideal for discovery chemistry,
the reliance on stoichiometric quantities of tin reagents, with
In a typical reaction, 1 equiv of 9a, 1.5 equiv of Ag2CO3,
and 20% Pd(OAc)2 were mixed in toluene, and then 2 equiv
of isonitrile 8a was slowly added at room temperature. A
clean transformation occurred, and after 20 h, a mixture of
product 10a and starting iodopyridone 9a in a 3:1 ratio was
obtained. Various attempts to push the reaction to completion
were not successful. Although excess isonitrile was used,
(5) (a) Govindachari, T. R.; Ravindranath, K. R.; Viswanathan, N. J.
Chem. Soc., Perkin Trans. 1 1974, 1215. (b) Pendrak, I.; Wittrock, R.;
Kingsbury, W. D. J. Org. Chem. 1995, 60, 2912. (c) Pirillo, A.; Verotta,
L.; Gariboldi, P.; Torregiani, E.; Bombardelli, E. J. Chem. Soc., Perkin
Trans. 1 1995, 583.
(6) The Camptothecins: Unfolding their Anticancer Potential; Liehr, J.
G., Giovanella, B. C., Verschraegen, C. F., Eds. Ann. N.Y. Acad. Sci. 2000,
922.
(7) Lavergne, O.; Lesueur-Ginot, L.; Rodas, F. P.; Kasprzyk, P. G.;
Pommier, J.; Demarquay, D.; Prevost, G.; Ulibarri, G.; Rolland, A.; Schiano-
Liberatore, A.-M.; Harnett, J.; Pons, D.; Camara, J.; Bigg, D. C. H. J. Med.
Chem. 1998, 41, 5410.
(8) (a) de Frutos, O.; Curran, D. P. J. Comb. Chem. 2000, 2, 639. (b)
Luo, Z. Y.; Zhang, Q. S.; Oderaotoshi, Y.; Curran, D. P. Science 2001,
291, 1766. (c) Zhang, W.; Chen, C. H.-T.; Luo, Z.; Curran, D. P. Submitted
for publication. (d) Curran, D. P.; Josien, H.; Bom, D.; Gabarda, A. E.;
Du, W. Ann. N.Y. Acad. Sci. 2000, 902, 112. (e) Gabarda, A.; Du, W.;
Isarno, T.; Tangirala, R. S.; Curran, D. P. Tetrahedron, in press.
(9) Bom, D.; Curran, D. P.; Kruszewski, S.; Zimmer, S. G.; Thompson
Strode, J. ; Kohlhagen, G.; Du, W.; Chavan, A. J.; Fraley, K. A.; Bingcang,
A. L.; Latus, L. J.; Pommier, Y.; Burke, T. G. J. Med. Chem. 2000, 43,
3970.
1
its presence was not detected in the H NMR spectrum of
the product mixture obtained after removing insoluble
materials. Once the reaction had stopped, addition of more
isonitrile or Pd catalyst alone did not result in further
conversion.
The reaction was finally driven to completion by a simple
recycle process. After filtration to remove insoluble material
(10) (a) Baguley, P. A.; Walton, J. C. Angew. Chem., Int. Ed. Engl. 1998,
37, 3073. (b) Studer, A.; Amrein, S. Synthesis, 2002, 835.
(11) Du, W. Ph.D. Thesis, University of Pittsburgh, 2002.
3216
Org. Lett., Vol. 4, No. 19, 2002